BBVA
QNCX icon

Banco Bilbao Vizcaya Argentaria’s Quince Therapeutics QNCX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25
Closed -$231K – 738
2020
Q2 		$231K Buy
+25
New +$229K 0.01% 683

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's QNCX Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Quince Therapeutics (QNCX) in Q3 2020, closing a stake of 25 shares — an estimated $231K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in QNCX in Q2 2020 and held it in 1 quarter. The position peaked at $231K in Q2 2020. 79 funds tracked by Wall St. Rank hold QNCX as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Quince Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 25 Quince Therapeutics shares in Q3 2020, an estimated $231K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Quince Therapeutics in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Quince Therapeutics position peaked at $231K in Q2 2020.
  • 79 funds tracked by Wall St. Rank held Quince Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.